Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Martínez-Maldonado, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martínez-Maldonado, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 63-66
© 2001 European Renal Association-European Dialysis and Transplant Association

Role of hypertension in the progression of chronic renal disease

Manuel Martínez-Maldonado

Ponce School of Medicine, Ponce, Puerto Rico 00732

Hypertension leads to renal disease through a series of mechanisms that seem to be exaggerated in African-Americans, who have a higher prevalence of both hypertension and end-stage renal disease than whites. Renal disease itself leads to hypertension, which in turn can contribute to progression of renal disease. Although there are numerous mechanisms involved in the process of renal disease progression, the renin–angiotensin system plays a major role as determined by the beneficial response to angiotensin I-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (AT II blockers) of reduced rate of progression in a variety of clinical and experimental renal diseases. Macromolecular trafficking across the glomerulus leading to proteinuria plays a significant role in progression of chronic renal disease. Reversal of this abnormality and reduced stress on capillary walls may be the major mechanisms of beneficial action of ACEIs and AT II blockers in halting renal disease progression.

Keywords: ACE inhibitors; angiotensin II; chronic renal disease; hypertension; renin–angiotensin system

Correspondence and offprint requests to: Dr Martínez-Maldonado, President and Dean, Ponce School of Medicine, PO Box 7004, Ponce, Puerto Rico.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
E. K. Sumaili, J.-M. Krzesinski, C. V. Zinga, E. P. Cohen, P. Delanaye, S. M. Munyanga, and N. M. Nseka
Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo
Nephrol. Dial. Transplant., August 20, 2008; (2008) gfn469v1.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. M. Leon, B. I. Freedman, M. B. Miller, K. E. North, S. C. Hunt, J. H. Eckfeldt, C. E. Lewis, A. T. Kraja, L. Djousse, and D. K. Arnett
Genome scan of glomerular filtration rate and albuminuria: the HyperGEN study
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 763 - 771.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
N. de las Heras, M. Ruiz-Ortega, M. Ruperez, D. Sanz-Rosa, M. Miana, P. Aragoncillo, S. Mezzano, V. Lahera, J. Egido, and V. Cachofeiro
Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2006; 7(4): 192 - 200.
[Abstract] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.